Company Overview
Dhampur Bio Organics Limited, together with its subsidiaries, manufactures and sells sugar in India and internationally. The company operates through three segments: Sugar; Biofuels and Spirits; and Country Liquor. It offers sulphurless sugar and sugar byproducts under the Dhampure brand name; ethanol and biogenic carbon dioxide; spirit and liquor; extra neutral alcohol; bagasse; and organic fertilizer. The company also engages in the cogeneration and sale of power. It exports its products. The company was incorporated in 2020 and is based in New Delhi, India.
Why Investors Should Care
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Mar 2026 Revenue of ₹2,073.76 Cr (+12.5% YoY); net profit ₹25.18 Cr.
- Trailing 12 Months Year-on-year growth — revenue -2.3%, earnings +71.4%.
- 5-Year Trend Long-term compounding — revenue CAGR -4.3%, profit CAGR -39.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -4.31% |
| 1 Year: | -2.30% |
Compounded Profit Growth
| 5 Years: | -39.03% |
| 1 Year: | 71.41% |
Stock Price Performance
| 1 Year: | +51.00% |
| 6 Months: | +10.70% |
| 3 Months: | -5.31% |
| 1 Month: | -0.72% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)55.74 · Neutral
P/E of 29.04 is above the sector median of 23.89 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -4.3% CAGR over 5 years.
- Earnings shrank at -39.0% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | DBOL Dhampur Bio Organics Limited NSE | 110.92 | 29.04 | ₹729.73 Cr | 1.34% | 7.72% | 2.45% | -4.31% | -39.03% |
| 2 | ADFFOODS ADF Foods Limited NSE | 261.40 | 31.23 | ₹2,871.83 Cr | 0.45% | 19.20% | 15.72% | 13.02% | 17.03% |
| 3 | AMIRCHAND AMIR CHAND JAG KUM (E) L | 185.11 | 18.55 | ₹1,916.84 Cr | 0.00% | 38.83% | 11.14% | 23.43% | 86.45% |
| 4 | ASALCBR Associated Alcohols & Breweries Limited NSE | 767.25 | 18.10 | ₹1,540.58 Cr | 0.24% | 16.23% | 12.73% | 13.46% | 28.64% |
| 5 | ALLTIME ALL TIME PLASTICS LIMITED NSE | 217.82 | 37.62 | ₹1,426.89 Cr | 0.00% | 9.05% | 8.21% | 11.40% | 7.80% |
| 6 | AVADHSUGAR Avadh Sugar & Energy Limited NSE | 609.25 | 21.28 | ₹1,219.62 Cr | 1.64% | 10.35% | 5.10% | -1.22% | -17.00% |
| 7 | APEX Apex Frozen Foods Limited NSE | 375.15 | 30.16 | ₹1,172.34 Cr | 0.52% | 10.66% | 7.36% | -4.47% | 2.69% |
| 8 | SCPL Sheetal Cool Products Limited NSE | 644.75 | 35.46 | ₹676.99 Cr | 0.00% | 17.86% | 13.27% | 2.46% | -2.23% |
| 9 | APTECHT Aptech Limited NSE | 97.00 | 23.89 | ₹562.63 Cr | 4.56% | 14.08% | 9.46% | 3.28% | -29.69% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 492.48 Cr | 557.69 Cr | 486.34 Cr | 539.70 Cr | 532.89 Cr |
| Cost of Revenue | 412.11 Cr | 484.46 Cr | 336.32 Cr | 332.19 Cr | 432.15 Cr |
| Gross Profit | 80.37 Cr | 73.23 Cr | 150.02 Cr | 207.51 Cr | 100.74 Cr |
| Operating Expenses | 83.86 Cr | 95.84 Cr | 122.69 Cr | 127.28 Cr | 104.68 Cr |
| Operating Income | -3.49 Cr | -22.61 Cr | 27.33 Cr | 80.23 Cr | -3.94 Cr |
| EBITDA | 10.19 Cr | 5.42 Cr | 51.59 Cr | 102.72 Cr | 10.15 Cr |
| Interest Expense | 18.88 Cr | 14.27 Cr | 10.60 Cr | 16.47 Cr | 15.56 Cr |
| Pretax Income | -20.88 Cr | -23.40 Cr | 25.68 Cr | 71.58 Cr | -18.29 Cr |
| Tax Provision | -6.79 Cr | -7.41 Cr | 8.78 Cr | 25.31 Cr | -4.54 Cr |
| Net Income | -14.09 Cr | -15.99 Cr | 16.90 Cr | 46.27 Cr | -13.75 Cr |
| Diluted EPS | -3.31 | -2.41 | 2.55 | 6.98 | 5.56 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | 2,366.62 Cr | 1,839.42 Cr | 1,842.69 Cr | 2,073.76 Cr |
| Cost of Revenue | 1,915.57 Cr | 1,474.80 Cr | 1,486.34 Cr | 1,718.56 Cr |
| Gross Profit | 451.05 Cr | 364.62 Cr | 356.35 Cr | 355.20 Cr |
| Operating Expenses | 279.15 Cr | 271.75 Cr | 274.32 Cr | 273.44 Cr |
| Operating Income | 171.90 Cr | 92.87 Cr | 82.03 Cr | 81.76 Cr |
| EBITDA | 213.38 Cr | 158.33 Cr | 134.15 Cr | 160.54 Cr |
| Interest Expense | 38.08 Cr | 43.36 Cr | 64.55 Cr | 60.20 Cr |
| Pretax Income | 134.77 Cr | 65.49 Cr | 15.71 Cr | 40.90 Cr |
| Tax Provision | 23.67 Cr | 19.00 Cr | 1.02 Cr | 15.72 Cr |
| Net Income | 111.10 Cr | 46.49 Cr | 14.69 Cr | 25.18 Cr |
| Diluted EPS | 16.74 | 7.00 | 2.21 | 3.80 |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 2,077.46 Cr | 2,312.81 Cr | 2,397.53 Cr | 2,322.13 Cr |
| Current Assets | - | 1,124.87 Cr | 1,251.56 Cr | 1,229.02 Cr | 1,179.02 Cr |
| Cash & Equivalents | - | 104.05 Cr | 5.99 Cr | 8.88 Cr | 8.71 Cr |
| Inventory | - | 819.28 Cr | 1,082.55 Cr | 1,094.32 Cr | 1,013.17 Cr |
| Receivables | - | 153.67 Cr | 87.53 Cr | 54.80 Cr | 63.78 Cr |
| Total Liabilities | - | 1,088.73 Cr | 1,301.34 Cr | 1,385.79 Cr | 1,295.49 Cr |
| Current Liabilities | - | 858.96 Cr | 1,052.00 Cr | 1,080.51 Cr | 1,012.23 Cr |
| Long Term Debt | - | 168.72 Cr | 176.95 Cr | 236.27 Cr | 206.98 Cr |
| Total Debt | - | 810.33 Cr | 1,056.95 Cr | 1,162.34 Cr | 1,060.46 Cr |
| Total Equity | - | 988.73 Cr | 1,011.47 Cr | 1,011.74 Cr | 1,026.64 Cr |
| Shares Outstanding | - | 6.64 Cr | 6.64 Cr | 6.64 Cr | 6.64 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 368.11 Cr | -101.33 Cr | 129.57 Cr | 219.86 Cr |
| Investing Cash Flow | - | -208.91 Cr | -166.29 Cr | -145.50 Cr | -41.54 Cr |
| Financing Cash Flow | - | -78.12 Cr | 169.56 Cr | 18.79 Cr | -178.49 Cr |
| Capital Expenditure | - | -223.32 Cr | -170.69 Cr | -145.74 Cr | -44.35 Cr |
| Free Cash Flow | - | 144.79 Cr | -272.02 Cr | -16.17 Cr | 175.51 Cr |
| Net Change in Cash | - | 81.08 Cr | -98.06 Cr | 2.86 Cr | -17.00 L |
Ratios (Annual)
Figures in %.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Gross Margin % | 19.1% | 19.8% | 19.3% | 17.1% |
| Operating Margin % | 7.3% | 5.0% | 4.5% | 3.9% |
| Net Margin % | 4.7% | 2.5% | 0.8% | 1.2% |
| ROE % | 11.2% | 4.6% | 1.5% | 2.5% |
| ROCE % | 14.1% | 7.4% | 6.2% | 6.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for DBOL
Three Days Left Until Dhampur Bio Organics Limited (NSE:DBOL) Trades Ex-Dividend - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi7AFBVV95cUxNRHI5c3BHTmVVbUxUSHlEU0JrdWdCcXA3Nnp4SmdFQXQteGEzODR3T243OE1tSGh3UTRveXpaX2VJSTg3dmNCTWRwTEEwTkVlVXpLcWFxVU95RldPaVZSVTBIYXVEYk5iM20xX1U4WGdSS3hRVEdhTnEtUUFGV1pHNGZzNUZPS3A5VGxhdW…
Dhampur Bio Organics Posts ₹38.4 Cr Profit as Q1 Revenue Surges 19% YoY - Sahi
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxQcWp0NWxzQUU2WEhOUE92bEFSVWNocUY2Ymwzc0QtcU5fTC1NaExlOFZHTzFzcVk0Q0cxQ2I4enFlQ3JyaDlrNC1VVnNQQThMS2w4YU04UDhnSXBjck1icjl1bGtJZ253YVdQWW5qbUpzUVl0OUNTWkg5QUpTLTh0cWNLVVZ0Y0locDUxVW…
There's Reason For Concern Over Dhampur Bio Organics Limited's (NSE:DBOL) Massive 30% Price Jump - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi7wFBVV95cUxNSHFjUDYxRTRndEtqM3Z3eHZEY1YtTklmLS1uR1ZlNlpUSXg0OHI1VHd6UnpIWmFOdlJFMHQ2QzZ4NjVnejZnRmVESzhHS0dpLWp5U0RHb2RaZTlEcFUwLTV0eGMwZ1lHT3ZPSWVxRnhoZlUzRjdRUXBMSU5POUI4VWlFcGRpQ0dYek51UV…
DBOL Stock Price and Chart — NSE:DBOL - TradingView
<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTE1RWGdnN2RtZ2k5M0YxR0QzTjRjQlBucDhmNm9CdGUwN2RwV0hjSUtoQ0p0TWs2dzlJUWlhcEY3Z01Ub2JBU1NQNFN0RTJPY2FLVm92MWoxbmM?oc=5" target="_blank">DBOL Stock Price and Chart — NSE:DBOL</a> &…
Dhampur Bio Organics Submits Q4FY26 SEBI Depositories Certificate Confirming No Physical Share Holdings - scanx.trade
<a href="https://news.google.com/rss/articles/CBMi8gFBVV95cUxQTFphVnIzNnhNejYxeUN1a203VVhzOVNidVRUWEVQRWQ2Y1FFenY1SVYwNktCYzNUR2lnWFF5N0E0MXhTN2dYUDA4M0JMLUl1bG1JVmFyOUtmdzF0OG5ldW9MQTgyOEoxNDBzZzZQcWROcmxjdktPS0pLb3lhQVVRRXdtaVhXeXo3Q3FDQ0…
DBOL Consolidated June 2026 Net Sales at Rs 532.89 crore, up 1.4% Y-o-Y - Moneycontrol.com
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxOWFNWMzRvZ3RhRVRQdC1DdmhrOTBidUlyX2I1MGFUbV9yc2Q1WC1ndG1CbXdOT1ZGRVJPLWd3YllhQkZsTVF1LWxROVJXOE1BYzhNYVYwNHJYaXFrNmRsZEFQZThFS3poMWJGTFN1cGt2S29kWDZ5YjI2czBpZUdFT0lTQjNEQm01RC1jMm…
DBOL — Frequently Asked Questions
What is the current share price of Dhampur Bio Organics Limited (DBOL)?
As of 2026-08-07 06:31 IST, Dhampur Bio Organics Limited (DBOL) trades at ₹110.92 on NSE. Its 52-week range is ₹68.48 to ₹126.32.
What is the market capitalisation of DBOL?
Dhampur Bio Organics Limited (DBOL) has a market capitalisation of ₹729.73 Cr on NSE.
What is the P/E ratio of DBOL?
DBOL trades at a trailing price-to-earnings (P/E) ratio of 29.04. The industry average P/E is 23.89. Its price-to-book (P/B) ratio is 0.72.
Does DBOL pay a dividend?
Dhampur Bio Organics Limited (DBOL) currently offers a dividend yield of 1.34%.
What is the return on equity (ROE) of DBOL?
DBOL has a return on equity (ROE) of 2.45%. Its return on capital employed (ROCE) is 7.72%.
Is DBOL a good stock to buy?
This page provides a data-driven analysis of Dhampur Bio Organics Limited (DBOL), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.